| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/15/2003 | EP1274735A1 PROCESS FOR EXTRACTION OF $g(b)-GLUCAN FROM CEREALS AND PRODUCTS OBTAINED THEREFROM |
| 01/15/2003 | EP1274726A2 Therapeutic compounds and methods for modulating v3, a versican isoform |
| 01/15/2003 | EP1274724A2 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties |
| 01/15/2003 | EP1274713A1 Anti-viral pyrimidine nucleoside analogues |
| 01/15/2003 | EP1274712A1 Novel flavone glycoside derivatives for use in cosmetics, pharmaceuticals and nutrition |
| 01/15/2003 | EP1274711A1 New aza-indolyl derivatives |
| 01/15/2003 | EP1274710A2 Novel heteroaryl-diazabicycloalkanes |
| 01/15/2003 | EP1274709A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines |
| 01/15/2003 | EP1274707A1 Therapeutically useful new salts of cck inhibitors, process for the preparation thereof and pharmaceutical preparations containing them |
| 01/15/2003 | EP1274706A1 Pyrazoles for inhibiting protein kinases |
| 01/15/2003 | EP1274705A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders |
| 01/15/2003 | EP1274701A1 Chemical compounds |
| 01/15/2003 | EP1274700A1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders |
| 01/15/2003 | EP1274699A1 Method for the preparation of 5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans |
| 01/15/2003 | EP1274698A1 Percyquinnin, a process for its production and its use as a pharmaceutical |
| 01/15/2003 | EP1274697A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 01/15/2003 | EP1274694A1 Novel compounds |
| 01/15/2003 | EP1274692A1 Quinazoline compounds |
| 01/15/2003 | EP1274691A1 2-guanidino-4-arylchinazolines as nhe-3 inhibitors |
| 01/15/2003 | EP1274687A1 1,2,3,4- tetrahydroisoquinoline derivatives |
| 01/15/2003 | EP1274686A1 Process for preparing 2-(4-chlorobenzolamino) -3- 2(1h) -quinolinon-4-yl]proprionic acid |
| 01/15/2003 | EP1274683A2 Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides |
| 01/15/2003 | EP1274682A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 01/15/2003 | EP1274676A2 Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade |
| 01/15/2003 | EP1274675A1 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 01/15/2003 | EP1274464A2 Compositions and methods for regulated protein expression in gut |
| 01/15/2003 | EP1274459A2 Sustained release formulations comprising growth hormone |
| 01/15/2003 | EP1274458A2 Compositions containing a naphthalmide and an antiproliferative agent |
| 01/15/2003 | EP1274457A2 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists |
| 01/15/2003 | EP1274456A2 Use of retinoid receptor antagonists or agonists in the treatment of cartilage and bone pathologies |
| 01/15/2003 | EP1274455A1 Cd40 antagonists for use in treating psoriasis and other inflammatory skin conditions |
| 01/15/2003 | EP1274452A1 Method of preventing or treating diabetes |
| 01/15/2003 | EP1274449A2 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 01/15/2003 | EP1274448A1 Method for improving the quality of sperm for artificial insemination of animals |
| 01/15/2003 | EP1274447A1 Pharmaceutical composition with a content of calcium or mixture of calcium and vitamin d or mixture of calcium and magnesium in a new formulation |
| 01/15/2003 | EP1274446A1 Polysaccharidic esters of n-derivatives of glutamic acid |
| 01/15/2003 | EP1274445A2 Use of steroidal alkaloids to reverse multidrug resistance |
| 01/15/2003 | EP1274444A1 Compounds for the treatment of psychiatric or substance abuse disorders |
| 01/15/2003 | EP1274443A1 Micelles |
| 01/15/2003 | EP1274442A1 Method for modulating tumor growth and metastasis of tumor cells |
| 01/15/2003 | EP1274441A1 Respiratory compositions |
| 01/15/2003 | EP1274440A1 Medical combinations comprising tiotropium and mometasone |
| 01/15/2003 | EP1274439A1 Medical combination comprising salmeterol and budesonide |
| 01/15/2003 | EP1274438A1 Medical combinations comprising tiotropium and budesonide |
| 01/15/2003 | EP1274437A1 Medical combinations comprising tiotropium and fluticasone proprionate |
| 01/15/2003 | EP1274436A1 Medical compositions comprising (r,r)-formoterol und rofleponide |
| 01/15/2003 | EP1274435A1 Medical combinations comprising formoterol and budesonide |
| 01/15/2003 | EP1274434A1 Medical combinations comprising tiotropium and rofleponide |
| 01/15/2003 | EP1274433A1 Medicaments for treating respiratory disorders comprising formoterol and fluticasone |
| 01/15/2003 | EP1274432A1 Compositions containing itraconazole with improved bioavailability and narrow intra- and inter-individual variation of its absorption |
| 01/15/2003 | EP1274431A1 10,11-difluoromethylenedioxycamptothecin compounds with topoisomerase i inhibition |
| 01/15/2003 | EP1274430A2 Compounds for treating fibromyalgia and chronic fatigue syndrome |
| 01/15/2003 | EP1274429A1 Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia |
| 01/15/2003 | EP1274428A2 Il-8 receptor antagonists |
| 01/15/2003 | EP1274427A1 Formulation of substituted benzimidazoles |
| 01/15/2003 | EP1274426A2 Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis |
| 01/15/2003 | EP1274425A1 Rapid-onset formulation of a selective cyclooxigenase-2 inhibitor |
| 01/15/2003 | EP1274424A1 Compounds and methods |
| 01/15/2003 | EP1274423A1 Medicine for treating traumatic brain injury and other neuronal disorders |
| 01/15/2003 | EP1274422A1 Method for treating cells resistant to antineoplastic agents |
| 01/15/2003 | EP1274421A2 Use of substances that act as cascade inhibitors of the raf/mek/erk signal cascade, for producing a medicament to treat dna and rna viruses |
| 01/15/2003 | EP1274420A1 Microbial inhibitory compositions |
| 01/15/2003 | EP1274418A1 Methods of use of penicillamines for the treatment of conditions resulting from dna damage |
| 01/15/2003 | EP1274417A2 Treatment of movement disorders with metabotropic glutamate receptor antagonists |
| 01/15/2003 | EP1274416A1 Dermatological use and a dermatological preparation |
| 01/15/2003 | EP1274415A2 Il-8 receptor antagonists |
| 01/15/2003 | EP1274414A1 Nasal administration of agents for the treatment of gastroparesis |
| 01/15/2003 | EP1274413A2 Il-8 receptor antagonists |
| 01/15/2003 | EP1274412A1 Pharmaceutical formulation |
| 01/15/2003 | EP1274411A1 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 01/15/2003 | EP1274410A2 Use of locally applied dna fragments |
| 01/15/2003 | EP1274409A2 Antiprogestins with partial agonist activity |
| 01/15/2003 | EP1274408A2 Use of natural chrysanthone compounds having antiangiogenic activity |
| 01/15/2003 | EP1274407A2 Uses of ppar-gamma agonists in neutrophil-induced diseases |
| 01/15/2003 | EP1274406A2 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
| 01/15/2003 | EP1274405A2 Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication |
| 01/15/2003 | EP1274404A1 Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents |
| 01/15/2003 | EP1274402A1 Pharmaceutical composition for the controlled release of paracetamol |
| 01/15/2003 | EP1274398A2 Effervescent granules and methods for their preparation |
| 01/15/2003 | EP1274397A2 Drug delivery composition and device |
| 01/15/2003 | EP1274322A1 Composition comprising free amino acids |
| 01/15/2003 | EP1274320A2 Conjugated linoleic acid powder |
| 01/15/2003 | EP1274319A2 Compositions and methods for improving vascular health |
| 01/15/2003 | EP1169317B1 Triarylimidazoles |
| 01/15/2003 | EP1163007B1 Propofol formulation containing tris |
| 01/15/2003 | EP1121929A4 Drug preparation "histochrome" for treating ocular conditions |
| 01/15/2003 | EP1112064B1 Method for preparing novel fenofibrate galenic formulations, galenic formulations obtained and applications |
| 01/15/2003 | EP1098901B1 Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines |
| 01/15/2003 | EP1063998B1 Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 01/15/2003 | EP1063995B1 Combination for the treatment of alcohol dependence containing an opioid antagonist and a nmda receptor complex modulator |
| 01/15/2003 | EP1062202B1 Cytostatic agents |
| 01/15/2003 | EP1059933B1 Use of parathyroide hormone consisting of aminoacid sequence 1-34 of human parathyroid hormone for reducing the risk of both vertebral and non vertebral bone fracture |
| 01/15/2003 | EP1023265B1 Azetidinone derivatives for the treatment of hcmv infections |
| 01/15/2003 | EP1015627A4 Method for detecting a target compound using a nucleic acid ligand |
| 01/15/2003 | EP1011653B1 Use of xanthophylles in medicaments for improvement of duration of muscle function or treatment of muscle disorders or diseases |
| 01/15/2003 | EP0991691B1 Polymer comprising unsaturated ester units and pharmaceutical and cosmetic compositions thereof |
| 01/15/2003 | EP0991405B1 Clear, injectable formulation of an anesthetic compound |
| 01/15/2003 | EP0977597B1 Improved methods for diagnostic imaging using a contrast agent and a vasodilator |
| 01/15/2003 | EP0954222A4 Gene therapy for proliferative vitreoretinopathy |
| 01/15/2003 | EP0941081B1 New use of creatine |